Open positions
About us
Absea is a transformative force in the protein engineering industry. Established in 2020, we are a fast-growing biotech company with currently over 250 employees across the globe.
Our cutting-edge platform for developing soluble proteins and monoclonal antibodies offers unparalleled throughput, enabling up to 1000 new development projects per month. Through dynamic collaborations with leaders in the life sciences, we have built a library of 12,000 soluble proteins and continue to broaden our synthetic proteome portfolio. Our monoclonal antibodies, validated for diverse applications, stand ready for widespread supply to the general market. Beyond this, we offer cutting-edge technological solution for proteomics and interactomics.
From our Innovation Center in Berlin, Manufacturing Centers in China, and Commercialization Center in the Bay Area, we cater to the needs of protein scientists as well as industry partners active in AI-driven protein design, diagnostics, and drug development.
Mission
We want to empower protein science by building a comprehensive resource uniting high-quality reagents, validation, data generation, and analysis tools. We strive to become a long-term partner for the world's leading labs, companies and service providersin the life sciences.
Benefits
Values
- Terms & conditions
- Privacy policy
- Report issue